India’s first intranasal vaccine for Covid gets DCGI blessing
New Delhi India’s first intranasal Covid vaccine by Bharat Biotech on Tuesday got the blessing from the medicine Controller General of India for 18 age group for confined use in exigency situation.
Publicizing the achievements, Union Health Minister Mansukh Mandaviya nominated it a ‘ big boost to India’s fight against Covid- 19.
“Big Boost to India’s Fight Against COVID- 19! Bharat Biotech’s ChAd36- SARS- CoV- S COVID- 19( Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by@CDSCO_INDIA_INF for primary immunization against COVID- 19 in 18 age group for confined use in exigency situation, ” Mandaviya twittered.
In the posterior tweet he said, “ This step will further strengthen our collaborative fight against the epidemic.
“India has work out its wisdom, R&D, and mortal coffers in the fight against COVID- 19 under PM@NarendraModi Ji’s leadership. With the wisdom- driven approach & Sabka Prayas, we will master COVID- 19 ”, he said.
No comments:
Post a Comment